IBD Case Challenges and Clinical Decision Support Tools: Practice Makes Perfect

Program Overview

In this activity, learners will hear Drs. Dulai, Vande Casteele, and Jairath discuss challenging real-world patient cases submitted by community-based clinicians across the United States. The faculty will explore each patient case in the context of how to apply the Clinical Decision Support Tool (CDST) developed by the US IBD Health Outcomes Consortium. With each case discussion, learners will gain insight on effective utilization of the CDST in their own practice, to help risk stratify and guide optimal treatment selection.

Credit Expired
CE Credit Expired
Expires: December 3, 2021

Target Audience

This activity is designed for gastroenterology and primary care clinicians involved in the care of patients with inflammatory bowel disease (IBD).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Employ predictive decision support tools to guide treatment initiation and timing in patients with inflammatory bowel disease (IBD) according to complication risk and disease severity
  • Use an individual’s probability of response to treatment to incorporate biologics into therapeutic regimens for IBD
  • Identify patients with IBD receiving biologic therapy who require more aggressive treatment, such as combination therapy and treat-to-target monitoring

Activity Faculty


Parambir Dulai, MD (Chair)

Assistant Professor
UC San Diego School of Medicine
La Jolla, CA


Niels Vande Casteele, PharmD, PhD

Assistant Professor, Medicine
UC San Diego School of Medicine
La Jolla, CA


Vipul Jairath, MBChB, DPhil, MRCP, FRCPC

Professor, Medicine
Departments of Medicine, Epidemiology and Biostatistics
John and Susan McDonald Endowed Chair, Inflammatory Bowel Disease Clinical Research
Division of Gastroenterology
Western University & London Health Sciences Centre
London, Ontario, Canada

Supporter Statement

Provider Statement

Disclosure of Financial Relationships


Planners and Managers

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | www.RMEI.com | (866) 770-RMEI


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources